Provided by Tiger Fintech (Singapore) Pte. Ltd.

Glaukos

88.30
-1.9600-2.17%
Post-market: 88.600.3000+0.34%17:45 EDT
Volume:772.04K
Turnover:67.97M
Market Cap:4.99B
PE:-31.82
High:89.86
Open:88.94
Low:87.17
Close:90.26
Loading ...

Glaukos Announces the Release of its 2024 Sustainability Report

Business Wire
·
16 Apr

Glaukos price target lowered to $175 from $200 at Mizuho

TIPRANKS
·
16 Apr

Glaukos Is Maintained at Overweight by Piper Sandler

Dow Jones
·
15 Apr

U.S. RESEARCH ROUNDUP- CNB Financial, Disney, Triumph Group

Reuters
·
15 Apr

Glaukos price target lowered to $114 from $155 at BTIG

TIPRANKS
·
14 Apr

Glaukos Is Maintained at Buy by Truist Securities

Dow Jones
·
11 Apr

Truist Cuts Price Target on Glaukos to $140 From $185, Keeps Buy Rating

MT Newswires Live
·
11 Apr

Strength Seen in Veracyte (VCYT): Can Its 13.0% Jump Turn into More Strength?

Zacks
·
10 Apr

Press Release: Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30

Dow Jones
·
09 Apr

What Makes Glaukos Corporation (GKOS) a Compelling Stock?

Insider Monkey
·
08 Apr

3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space

Zacks
·
31 Mar

Glaukos Corporation (NYSE:GKOS) Is Expected To Breakeven In The Near Future

Simply Wall St.
·
27 Mar

Breakeven On The Horizon For Glaukos Corporation (NYSE:GKOS)

Simply Wall St.
·
24 Mar

RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution

Business Wire
·
11 Mar

Is Glaukos Corporation (GKOS) the Best Medical Technology Stock to Buy According to Analysts?

Insider Monkey
·
05 Mar

Glaukos’s Strong Market Position and Growth Prospects Justify Buy Rating

TIPRANKS
·
04 Mar

Stifel Nicolaus Reaffirms Their Buy Rating on Glaukos (GKOS)

TIPRANKS
·
03 Mar

Glaukos CEO Makes a Multi-Million Dollar Stock Sale!

TIPRANKS
·
01 Mar

GKOS Crashes Almost 25% After Q4 Earnings: How to Play the Stock?

Zacks
·
28 Feb

BRIEF-Glaukos Announces FDA Acceptance Of NDA Submission For Epioxa™

Reuters
·
24 Feb